Bristol Drops Virology Discovery In Latest R&D Reshuffling
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm plans to expand presence in Boston and San Francisco, while shuttering or de-emphasizing other locations, and to end virology discovery, in line with R&D strategy introduced in 2013.